Thompson Siegel & Walmsley’s Adeptus Health Inc ADPT Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,200	Closed	-$30K	–	735
2014 Q3	$30K	Buy	+1,200	New	+$31.3K	﹤0.01%	507

Other funds holding ADPT

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thompson Siegel & Walmsley's ADPT Position: Q4 2014 in Review

Thompson Siegel & Walmsley sold out of Adeptus Health Inc (ADPT) in Q4 2014, closing a stake of 1,200 shares — an estimated $30K sold.

Thompson Siegel & Walmsley first reported a position in ADPT in Q3 2014 and held it in 1 quarter. The position peaked at $30K in Q3 2014. 63 funds tracked by Wall St. Rank hold ADPT as of Q4 2014.

Thompson Siegel & Walmsley reported no remaining Adeptus Health Inc position as of Q4 2014 after selling out during the quarter.
Thompson Siegel & Walmsley sold 1,200 Adeptus Health Inc shares in Q4 2014, an estimated $30K.
Thompson Siegel & Walmsley first reported a position in Adeptus Health Inc in Q3 2014 and held it in 1 quarter.
Thompson Siegel & Walmsley's Adeptus Health Inc position peaked at $30K in Q3 2014.
63 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q4 2014.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2014, filed 9 Feb 2015.